Serena Williams' suggestion that injectable weight loss drugs could have helped her in tennis is part of an ongoing ...

Ozempic and other GLP-1 weight-loss medications are seeing explosive growth in popularity, but they’re also facing billions ...

The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

Serena Williams broke her silence about her weight loss journey, revealing she used medication to help her lose 31 pounds.

Williams has been making headlines lately for her significant weight loss transformation. And now she's opening up about it!

Dr Shazia Malik - a consultant obstetrician and gynaecologist for The Portland Hospital - discussed the pros and cons of ...

Serena Williams shared a bikini pic after losing 31 pounds with GLP-1 medication, reflecting on her health challenges and ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...

Serena Williams has revealed a transformative chapter in her health journey. At 43, the 23-time Grand Slam champion told ...

The retired tennis pro explained that she’s trying to combat the stigma associated with weight loss drugs after losing 31 ...